Skip to content

AARD AARD Total Current Liabilities

Total Current Liabilities at other companies

AbbVie logo
AbbVieABBV
$42.1B+15.6%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$12.89M+146%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$103.2M-7.7%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$31.75M+73.5%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$106.33M+443%
Arvinas logo
ArvinasARVN
$115.9M-45.8%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's total current liabilities?
AARD (AARD) reported total current liabilities of $11.6M in Q1 2026.
How has AARD's total current liabilities changed year-over-year?
AARD's total current liabilities increased by 94.2% year-over-year, from $5.98M to $11.6M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.